5-MeO-DALT
From Wikipedia, the free encyclopedia
 |
|
|
5-MeO-DALT
|
|
| Systematic (IUPAC) name | |
| N-allyl-N-[2-(5-methoxy -1H-indol-3-yl)ethyl] prop-2-en-1-amine |
|
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C17H22N2O |
| Mol. mass | 270.375 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
5-MeO-DALT or N,N-diallyl-5-methoxytryptamine is a psychedelic tryptamine presumed to be first synthesized by Alexander Shulgin.
Contents |
[edit] Chemistry
The full name of the chemical is N-allyl-N-[2-(5-methoxy
-1H-indol-3-yl)ethyl]prop-2-en-1-amine. It is very closely related to the compound 5-MeO-DPT and DALT.
[edit] Dosage
5-MeO-DALT is usually taken orally at dosages of 12-25mg.
[edit] Effects
Some users report 5-MeO-DALT produces rapid, intense entheogenic effects, and it is very short-acting; effects are usually over within 2-4 hours. While other users assert it has absolutely no psychoactive effect. According to many users, the compound is said to be completely void of visual/hallucinogenic activity, unlike other closely related substances.
[edit] Dangers
There have been no reported deaths or hospitalizations from 5-MeO-DALT, but its safety profile is unknown.
[edit] Legality
5-MeO-DALT is unscheduled and uncontrolled in the United States, but possession and sales of 5-MeO-DALT could be prosecuted under the Federal Analog Act because of its structural similarities to other Schedule I substances.
[edit] External links
|
|||||
|
|||||
